Copyright
©The Author(s) 2017.
World J Gastroenterol. Apr 7, 2017; 23(13): 2396-2403
Published online Apr 7, 2017. doi: 10.3748/wjg.v23.i13.2396
Published online Apr 7, 2017. doi: 10.3748/wjg.v23.i13.2396
Figure 2 The mean changes in serum HBV DNA levels of the decompensated and compensated cirrhosis group.
There were no significant differences in the reduction of serum HBV DNA levels between two groups (P = 0.310). LC: Liver cirrhosis.
- Citation: Lee SK, Song MJ, Kim SH, Lee BS, Lee TH, Kang YW, Kim SB, Song IH, Chae HB, Ko SY, Lee JD. Safety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis. World J Gastroenterol 2017; 23(13): 2396-2403
- URL: https://www.wjgnet.com/1007-9327/full/v23/i13/2396.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i13.2396